National Sickle Cell and Thalassemia Blood Group Genotyping Programme
NHS Englandservices
What the buyer wrote
12-month programme will enable genotyping of blood groups by NHS BT in current patients (up to 17,800 patients) with either sickle cell or thalassemia.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- National Sickle Cell and Thalassemia Blood Group Genotyping Programme
- How they are buying
- Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
- Type
- services
- Kind of work
- Mental health and wellbeing services
Who the buyer named
NHSE Commercial was the named contact on this notice.